Recent Developments of Novel Pharmacologic Therapeutics for Prevention of Chemotherapy-Induced Peripheral Neuropathy
Shuiying Hu(The Ohio State University), Maryam B. Lustberg(Yale Cancer Center), Charles L. Loprinzi(Mayo Clinic in Arizona), Kevin M. Huang(The Ohio State University), Elizabeth Adams(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 89
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline
|Journal of Clinical Oncology|2005|565